| Literature DB >> 17439656 |
Carol Iversen1, Angelika Lehner, Niall Mullane, Eva Bidlas, Ilse Cleenwerck, John Marugg, Séamus Fanning, Roger Stephan, Han Joosten.
Abstract
BACKGROUND: Enterobacter sakazakii is an opportunistic pathogen that can cause infections such as necrotizing enterocolitis, bacteraemia, meningitis and brain abscess/lesions. When the species was defined in 1980, 15 biogroups were described and it was suggested that these could represent multiple species. In this study the taxonomic relationship of strains described as E. sakazakii was further investigated.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17439656 PMCID: PMC1868726 DOI: 10.1186/1471-2148-7-64
Source DB: PubMed Journal: BMC Evol Biol ISSN: 1471-2148 Impact factor: 3.260
Figure 116S rRNA gene phylogenetic tree of . A Neighbor-Joining analysis was used with Felsenstein correction (1000 bootstrap replicates). The bar indicates 10% estimated sequence divergence.
Figure 2f-AFLP dendogram of . A DICE coefficient and UPGMA algorithm were used with an optimization of 0% and position tolerance of 0.2%. The scale bar represents the percentage of similarity.
Figure 3Ribotype dendogram of . A DICE coefficient and UPGMA algorithm were used with an optimization of 1% and position tolerance of 1.5%. The scale bar represents the percentage of similarity.
DNA-DNA % relatedness of Cronobacter strains (in 2 × SSC + 5% formamide at 70°C)
| 70.0 (2.4)§ | |||||
| 51.8 (2.8) | 51.9 (2.6) | ||||
| 53.3 (3.0) | 42.0 (4.0) | 56.0 (4.2) | |||
| 37.7 (1.8) | 31.3 (6.2) | 91.9 (4.9) | |||
| 16.7 (7.6) | 43.0 (9.8) | 36.8 (2.2) | 54.5 (4.7) | ||
| 37.3 (0.0) | 54.8 (2.1) | 77.4 (7.5) | |||
| 55.5 (1.0) | 54.4 (3.9) | 55.0 (3.3) | 53.1 (6.6) | 45.9 (2.0) |
§% relatedness values are averages of duplicate measurements and standard deviations are given in parentheses (values can be reproduced in a range of about 10%).
16S rRNA gene % similarity of Cronobacter species type strains to Cronobacter species and related Enterobacteriaceae.
| (44)§ | 99.6 ± 0.232 | 98.9 ± 0.13 | 98.9 ± 0.13 | 98.3 ± 0.19 | 98.9 ± 0.18 | |
| (8) | 98.7 ± 0.08 | 100.0 ± 0.04 | 99.5 ± 0.07 | 98.4 ± 0.07 | 99.6 ± 0.07 | |
| (7) | 98.7 ± 0.19 | 99.4 ± 0.14 | 99.6 ± 0.24 | 98.4 ± 0.17 | 99.2 ± 0.17 | |
| (7) | 97.9 ± 0.00 | 98.4 ± 0.13 | 98.3 ± 0.15 | 99.9 ± 0.20 | 98.7 ± 0.10 | |
| (2) | 98.5 ± 0.00 | 99.6 ± 0.00 | 99.1 ± 0.00 | 98.6 ± 0.00 | 100.0 ± 0.00 | |
| (5) | 96.8 ± 0.46 | 96.5 ± 0.33 | 96.5 ± 0.32 | 97.1 ± 0.44 | 96.7 ± 0.34 | |
| (24) | 96.8 ± 0.04 | 96.6 ± 0.16 | 96.4 ± 0.08 | 97.2 ± 0.12 | 96.7 ± 0.12 |
§number of full-length 16S rRNA gene sequences compared. 2mean % similarity of the sequences to the Cronobacter species type strains ± standard deviation.
Statistically relevant biochemical tests for the differentiation of proposed Cronobacter species and subspecies.
| Dul | Ind | Malo | AMG | ||
| (163)§ | - | - | - | + | |
| (22) | - | - | + | + | |
| (7) | + | + | + | - | |
| (8) | - | + | v | + | |
| (8) | + | - | + | + | |
| (2) | + | - | + | + |
§number of isolates; Dul, production of acid from dulcitol; Ind, production of indole; Malo, malonate utilization; AMG, production of acid from methyl-α-D-glucoside; +, 85–100% positive; v, 15–85% positive; -, less than 15% positive.
Biochemical differentiation of Cronobacter from other Enterobacteriaceae.
| 4-NP-α-Glc | VP | ADH | ODC | SAC | RAF | CEL | ARA | CIT | MR | ADO | SOR | LDC | H2S | |
| + | + | + | + | + | + | + | + | + | - | - | - | - | - | |
| v | - | - | + | - | + | + | + | + | + | - | - | - | - | |
| - | - | v | + | v | - | + | + | + | + | + | + | - | - | |
| - | - | v | - | v | v | v | + | v | + | - | + | - | + | |
| - | - | - | + | - | - | - | - | - | + | - | - | + | + | |
| - | + | - | + | + | + | + | + | + | - | + | + | + | - | |
| - | - | v | + | + | v | + | + | + | + | - | + | - | - | |
| - | + | + | + | - | - | + | + | + | - | - | - | - | - | |
| - | + | + | + | + | + | + | + | + | - | v | + | - | - | |
| - | + | - | + | + | + | + | + | + | - | - | - | + | - | |
| - | + | v | + | + | - | + | + | + | v | - | - | - | - | |
| v | v | - | + | + | - | + | + | - | v | - | - | + | - | |
| + | - | - | - | - | - | + | + | - | + | - | - | - | - | |
| + | - | - | - | - | - | + | + | - | + | - | - | - | - | |
| - | - | v | v | v | v | - | + | - | + | - | + | (+) | - | |
| (-) | (+) | - | + | - | - | (-) | + | - | v | - | - | + | - | |
| (-) | + | - | - | + | + | + | + | + | - | + | + | + | - | |
| v | - | - | + | + | + | + | + | (+) | + | - | v | v | - | |
| - | - | - | - | v | v | + | + | - | + | + | - | - | - | |
| - | - | - | + | - | - | - | - | - | + | - | - | - | (-) | |
| - | v | - | - | v | v | v | + | v | v | - | v | - | - | |
| + | - | - | v | (+) | - | - | - | v | v | - | - | - | + | |
| - | - | - | - | v | - | - | - | v | + | v | - | - | v | |
| - | - | v | - | + | + | + | + | (-) | - | - | + | - | - | |
| - | + | - | (-) | + | + | + | + | v | v | + | + | + | - | |
| Salmonella sv. | - | - | v | (+) | - | - | v | (+) | v | + | - | v | (+) | v |
| v | + | - | + | + | - | - | - | + | (-) | v | + | + | - | |
| - | - | - | + | + | - | v | + | - | + | - | + | - | - |
4-NP-α-Glc, metabolism of 4-NP-α-glucoside; VP, Voges-Proskauer; ADH, arginine dihydrolase; ODC, ornithine decarboxylase; SAC, acid from sucrose; RAF, acid from raffinose; CEL, acid from cellobiose; ARA, acid from arabinose; CIT, use of citrate as sole carbon source (Simmon's); ADO, acid from adonitol; SOR, acid from sorbitol; LDC, lysine decarboxylase; MR, methly red test; H2S, production of hydrogen sulphide. +, 90–100% positive; (+), 80–90% positive; v, 20–80% positive; (-), 10–20% positive; -, less than 10% positive. Data was derived from this study and from Manual of Clinical Microbiology, 7th Edition [25]. *Enterobacter helveticus and E. turicensis are novel Enterobacter species [38].